Hair Relaxer & Uterine Cancer Risk - Episode #55

By Tamara Thomas - Last Updated: August 1, 2023
Also available on the following streaming services
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links

On this episode, we discuss research that says drug prices don’t reflect R&D cost; transgender men and the abortion fight; hair relaxer and uterine cancer risk; and more.

Advertisement

Related Podcasts

Interviews with Key Healthcare Opinion Leaders – Episode #75
Interviews with Key Healthcare Opinion Leaders - Episode #74
Interviews with Key Healthcare Opinion Leaders - Episode #73
Interviews with Key Healthcare Opinion Leaders - Episode #72
Nicole Eggert Breast Cancer Diagnosis; Microplastics in Water; Desmoid Tumor Awareness - Episode #71
Advertisement
Advertisement
Latest News

Study Finds VLDL-C, Lipid Discordance Increase the Risk of ASCVD

April 19, 2024

Quinton Maidment Discusses the Clinical Trial Enrollment Process, Part 1

April 19, 2024

Genetics May Influence Estrogen Levels, Endometrial Cancer Risk in Postmenopausal Women

April 18, 2024

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • Who We Are

    About Us

    Editorial Policy

    Contributors & Partners

    Connect

    eNewsletters

    Contact Us

    Work With Us

    Advertising

    Our Network

    GU Oncology Now

    Blood Cancers Today

    Cancer Nursing Today

    DocWire News

    MashupMD

    © 2024 Mashup Media, LLC. All rights reserved.

    Terms of Use | Privacy Policy